PCBL Chemical Ltd.
PCBLCommodities filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
18 transcript(s)/analyst meet(s) served; 10 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 18 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20220426 | 2022-03-31 | no | |
| COVER_LETTER | 20220727 | 2022-06-30 | no | |
| COVER_LETTER | 20221101 | 2022-09-30 | no | |
| COVER_LETTER | 20230206 | 2022-12-31 | no | |
| COVER_LETTER | 20230522 | 2023-03-31 | no | |
| COVER_LETTER | 20230719 | 2023-06-30 | no | |
| COVER_LETTER | 20231202 | 2023-09-30 | no | |
| COVER_LETTER | 20231021 | 2024-03-31 | no | |
| COVER_LETTER | 20240528 | 2024-03-31 | no | |
| COVER_LETTER | 20240816 | 2024-06-30 | no | |
| TRANSCRIPT | 20241106 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250117 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250505 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250730 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251024 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260209 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260507 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260805 | 2026-06-30 | yes |
PCBL
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
The closes are adjusted for every split and bonus on record inside the period this series covers, and each adjustment is checked against the price move on its ex-date.
| Last close | 338.60 |
| 52-week range | 232.15 – 389.7 |
| Return 1M | 5.45% |
| Return 3M | 6.68% |
| Return 1Y | -13.11% |
| Return 3Y | 110.44% |
| Return 5Y | not reported for this period |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 2,473.00 |
| Other income | 4.00 |
| Total income | 2,478.00 |
| Cost of materials consumed | 1,767.00 |
| Purchases of stock-in-trade | 0.00 |
| Changes in inventories | -117.00 |
| Employee benefit expense | 130.00 |
| Finance costs | 93.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.53 | 0.00 |
| institutions foreign | 0.06 | 0.00 |
| institutions domestic | 0.11 | 0.00 |
| mutual funds | 0.06 | 0.00 |
| public | 0.47 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| COVER_LETTER | 2024-06-30 | 10 |
| TRANSCRIPT | 2026-06-30 | 8 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,628.00 | 1,363.00 | 1,374.00 | 1,348.00 | 1,487.00 | 1,657.00 | 1,929.00 | 2,144.00 | 2,163.00 | 2,010.00 | 2,087.00 | 2,114.00 | 2,164.00 | 1,846.00 | 2,066.00 | 2,473.00 |
| Other income | 4.00 | 9.00 | 17.00 | 4.00 | 3.00 | 7.00 | 23.00 | 11.00 | 6.00 | 11.00 | 20.00 | 6.00 | 12.00 | 16.00 | 5.00 | 4.00 |
| Total income | 1,632.00 | 1,372.00 | 1,390.00 | 1,352.00 | 1,489.00 | 1,664.00 | 1,952.00 | 2,154.00 | 2,169.00 | 2,021.00 | 2,107.00 | 2,120.00 | 2,176.00 | 1,862.00 | 2,071.00 | 2,478.00 |
| Cost of materials consumed | 1,309.00 | 1,063.00 | 957.00 | 930.00 | 1,090.00 | 1,202.00 | 1,311.00 | 1,436.00 | 1,513.00 | 1,434.00 | 1,454.00 | 1,447.00 | 1,497.00 | 1,350.00 | 1,380.00 | 1,767.00 |
| Purchases of stock-in-trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 13.00 | 2.00 | 1.00 | 1.00 | 10.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Changes in inventories | -51.00 | -19.00 | 68.00 | 5.00 | -42.00 | -38.00 | 5.00 | 0.00 | -16.00 | -50.00 | 22.00 | -3.00 | 28.00 | -65.00 | 71.00 | -117.00 |
| Employee benefit expense | 49.00 | 48.00 | 47.00 | 52.00 | 56.00 | 61.00 | 81.00 | 100.00 | 98.00 | 105.00 | 109.00 | 109.00 | 124.00 | 116.00 | 113.00 | 130.00 |
| Finance costs | 11.00 | 15.00 | 19.00 | 19.00 | 21.00 | 32.00 | 108.00 | 121.00 | 119.00 | 118.00 | 103.00 | 112.00 | 107.00 | 106.00 | 97.00 | 93.00 |
| Depreciation and amortisation | 33.00 | 33.00 | 34.00 | 41.00 | 48.00 | 53.00 | 75.00 | 84.00 | 86.00 | 87.00 | 88.00 | 92.00 | 93.00 | 94.00 | 94.00 | 103.00 |
| Other expenses | 132.00 | 108.00 | 119.00 | 149.00 | 144.00 | 152.00 | 221.00 | 236.00 | 203.00 | 202.00 | 204.00 | 231.00 | 244.00 | 230.00 | 259.00 | 297.00 |
| Total expenses | 1,483.00 | 1,248.00 | 1,242.00 | 1,197.00 | 1,318.00 | 1,463.00 | 1,803.00 | 1,991.00 | 2,005.00 | 1,897.00 | 1,981.00 | 2,000.00 | 2,097.00 | 1,831.00 | 2,014.00 | 2,274.00 |
| Profit before exceptional items and tax | 149.00 | 124.00 | 148.00 | 154.00 | 172.00 | 201.00 | 149.00 | 164.00 | 164.00 | 124.00 | 126.00 | 120.00 | 78.00 | 31.00 | 57.00 | 204.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | -21.00 | -4.00 | 0.00 |
| Profit before tax | 149.00 | 124.00 | 148.00 | 154.00 | 172.00 | 201.00 | 149.00 | 164.00 | 164.00 | 124.00 | 126.00 | 120.00 | 78.00 | 10.00 | 52.00 | 204.00 |
| Current tax | 40.00 | 21.00 | 57.00 | 43.00 | 48.00 | 48.00 | 46.00 | 59.00 | 53.00 | 22.00 | 45.00 | 32.00 | 22.00 | 18.00 | 12.00 | 44.00 |
| Deferred tax | -8.00 | 5.00 | -11.00 | 2.00 | 1.00 | 5.00 | -8.00 | -13.00 | -13.00 | 8.00 | -19.00 | -6.00 | -5.00 | -10.00 | -0.00 | 5.00 |
| Tax expense | 32.00 | 27.00 | 46.00 | 45.00 | 49.00 | 53.00 | 38.00 | 46.00 | 40.00 | 30.00 | 26.00 | 26.00 | 17.00 | 8.00 | 12.00 | 49.00 |
| Profit for the period | 116.00 | 97.00 | 102.00 | 109.00 | 123.00 | 148.00 | 111.00 | 118.00 | 123.00 | 93.00 | 100.00 | 94.00 | 62.00 | 2.00 | 40.00 | 155.00 |
| Profit attributable to owners | 116.00 | 97.00 | 102.00 | 109.00 | 123.00 | 148.00 | 111.00 | 118.00 | 123.00 | 93.00 | 100.00 | 94.00 | 62.00 | 2.00 | 40.00 | 155.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Other comprehensive income | 22.00 | -8.00 | -21.00 | 18.00 | 36.00 | 95.00 | -16.00 | 69.00 | 145.00 | -51.00 | -43.00 | 34.00 | -15.00 | -16.00 | -1.00 | 47.00 |
| Total comprehensive income | 138.00 | 90.00 | 82.00 | 128.00 | 158.00 | 243.00 | 95.00 | 187.00 | 268.00 | 42.00 | 57.00 | 128.00 | 47.00 | -14.00 | 39.00 | 202.00 |
| Earnings per share, basic | 3.08 | 2.57 | 2.71 | 2.89 | 3.25 | 3.92 | 2.95 | 3.13 | 3.27 | 2.47 | 2.65 | 2.49 | 1.63 | 0.05 | 1.02 | 3.94 |
| Earnings per share, diluted | 3.08 | 2.57 | 2.71 | 2.89 | 3.25 | 3.92 | 2.95 | 3.13 | 3.26 | 2.46 | 2.64 | 2.48 | 1.62 | 0.05 | 1.02 | 3.94 |
Annual results, as filed
| Line | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 3,244.00 | 2,660.00 | 4,446.00 | 5,774.00 | 6,420.00 | 8,404.00 | 8,189.00 |
| Other income | 29.00 | 18.00 | 29.00 | 41.00 | 37.00 | 47.00 | 39.00 |
| Total income | 3,273.00 | 2,678.00 | 4,475.00 | 5,815.00 | 6,457.00 | 8,452.00 | 8,228.00 |
| Cost of materials consumed | 2,186.00 | 1,584.00 | 3,169.00 | 4,356.00 | 4,534.00 | 5,836.00 | 5,674.00 |
| Purchases of stock-in-trade | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 17.00 | 14.00 |
| Changes in inventories | 4.00 | 25.00 | -35.00 | -4.00 | -70.00 | -44.00 | 31.00 |
| Employee benefit expense | 135.00 | 132.00 | 159.00 | 190.00 | 250.00 | 413.00 | 463.00 |
| Finance costs | 46.00 | 34.00 | 29.00 | 53.00 | 181.00 | 461.00 | 423.00 |
| Depreciation and amortisation | 92.00 | 110.00 | 121.00 | 137.00 | 217.00 | 346.00 | 373.00 |
| Other expenses | 455.00 | 400.00 | 501.00 | 500.00 | 666.00 | 845.00 | 964.00 |
| Total expenses | 2,918.00 | 2,285.00 | 3,943.00 | 5,233.00 | 5,780.00 | 7,874.00 | 7,942.00 |
| Profit before exceptional items and tax | 355.00 | 392.00 | 532.00 | 582.00 | 676.00 | 578.00 | 286.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 | -25.00 |
| Profit before tax | 355.00 | 392.00 | 532.00 | 582.00 | 676.00 | 577.00 | 261.00 |
| Current tax | 57.00 | 69.00 | 110.00 | 157.00 | 185.00 | 179.00 | 85.00 |
| Deferred tax | 10.00 | 9.00 | -5.00 | -17.00 | -0.00 | -37.00 | -22.00 |
| Tax expense | 67.00 | 78.00 | 105.00 | 139.00 | 185.00 | 142.00 | 63.00 |
| Profit for the period | 288.00 | 314.00 | 426.00 | 442.00 | 491.00 | 435.00 | 198.00 |
| Profit attributable to owners | 287.00 | 314.00 | 426.00 | 442.00 | 491.00 | 435.00 | 198.00 |
| Profit attributable to non-controlling interests | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other comprehensive income | -89.00 | 43.00 | 52.00 | -18.00 | 133.00 | 120.00 | 2.00 |
| Total comprehensive income | 199.00 | 357.00 | 478.00 | 425.00 | 624.00 | 554.00 | 200.00 |
| Earnings per share, basic | 4.23 | 18.22 | 11.81 | 11.70 | 13.00 | 11.51 | 5.15 |
| Earnings per share, diluted | 16.68 | 18.22 | 11.81 | 11.70 | 13.00 | 11.48 | 5.13 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 5,524.00 | 5,433.00 | 6,057.00 | 11,295.00 | 11,745.00 | 11,722.00 | 11,686.00 | 11,295.00 |
| Non-current assets | 2,966.00 | 3,420.00 | 3,728.00 | 7,857.00 | 8,345.00 | 7,997.00 | 8,254.00 | 8,327.00 |
| Current assets | 2,558.00 | 2,012.00 | 2,328.00 | 3,439.00 | 3,400.00 | 3,724.00 | 3,432.00 | 2,968.00 |
| Property, plant and equipment | 1,877.00 | 1,962.00 | 2,976.00 | 3,560.00 | 3,621.00 | 3,548.00 | 3,977.00 | 4,417.00 |
| Capital work-in-progress | 645.00 | 1,130.00 | 359.00 | 433.00 | 541.00 | 730.00 | 731.00 | 566.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 1,161.00 | 1,161.00 | 607.00 | 607.00 | 607.00 |
| Other intangible assets | 1.00 | 1.00 | 1.00 | 2,166.00 | 2,251.00 | 2,204.00 | 2,152.00 | 2,099.00 |
| Inventories | 641.00 | 571.00 | 688.00 | 999.00 | 981.00 | 1,268.00 | 1,072.00 | 1,024.00 |
| Trade receivables | 1,404.00 | 1,111.00 | 1,216.00 | 1,710.00 | 1,775.00 | 1,794.00 | 1,757.00 | 1,395.00 |
| Cash and cash equivalents | 123.00 | 40.00 | 72.00 | 312.00 | 183.00 | 319.00 | 217.00 | 230.00 |
| Total equity and liabilities | 5,524.00 | 5,433.00 | 6,057.00 | 11,295.00 | 11,745.00 | 11,722.00 | 11,686.00 | 11,295.00 |
| Equity | 2,876.00 | 2,839.00 | 3,125.00 | 3,250.00 | 3,821.00 | 3,709.00 | 3,884.00 | 4,019.00 |
| Equity share capital | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 39.00 |
| Other equity | 2,829.00 | 2,792.00 | 3,078.00 | 3,209.00 | 3,776.00 | 3,660.00 | 3,833.00 | 3,967.00 |
| Total liabilities | 2,649.00 | 2,594.00 | 2,931.00 | 8,045.00 | 7,923.00 | 8,013.00 | 7,802.00 | 7,275.00 |
| Non-current liabilities | 766.00 | 742.00 | 857.00 | 4,834.00 | 4,631.00 | 4,116.00 | 3,868.00 | 3,688.00 |
| Current liabilities | 1,882.00 | 1,852.00 | 2,074.00 | 3,211.00 | 3,292.00 | 3,897.00 | 3,934.00 | 3,587.00 |
| Borrowings, non-current | 416.00 | 407.00 | 456.00 | 3,777.00 | 3,575.00 | 3,647.00 | 3,374.00 | 3,197.00 |
| Borrowings, current | 625.00 | 536.00 | 556.00 | 1,043.00 | 1,176.00 | 1,733.00 | 1,701.00 | 1,628.00 |
| Trade payables | 1,019.00 | 956.00 | 1,260.00 | 1,802.00 | 1,713.00 | 1,595.00 | 1,672.00 | 1,447.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | -16.00 | 504.00 | 384.00 | 1,105.00 | 434.00 | 760.00 | 822.00 | 1,576.00 |
| Net cash from investing activities | -286.00 | -552.00 | -352.00 | -4,214.00 | -413.00 | -690.00 | -406.00 | -675.00 |
| Net cash from financing activities | 306.00 | -31.00 | 1.00 | 3,381.00 | -151.00 | -64.00 | -518.00 | -990.00 |
| Purchase of property, plant and equipment | 462.00 | 896.00 | 339.00 | 536.00 | 424.00 | 774.00 | 413.00 | 727.00 |
| Net increase in cash | 4.00 | -78.00 | 32.00 | 272.00 | -130.00 | 6.00 | -101.00 | -89.00 |
| con:CFO.BEFORE_TAX | 61.00 | 682.00 | 471.00 | 1,335.00 | 520.00 | 938.00 | 852.00 | 1,643.00 |
| con:INTEREST_RECEIVED.OPERATING | -1.00 | -3.00 | -2.00 | -7.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | -10.00 | 0.00 | -8.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 76.00 | 166.00 | 85.00 | 216.00 | 86.00 | 178.00 | 30.00 | 67.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 2,362.00 | 5,158.00 | 1,352.00 | 6,029.00 | 2,894.00 | 6,024.00 | 3,082.00 | 7,995.00 |
| con:INVESTMENTS_SOLD | 2,539.00 | 5,500.00 | 1,336.00 | 6,043.00 | 2,901.00 | 6,076.00 | 3,088.00 | 8,015.00 |
| con:PPE_DISPOSALS | 0.00 | 0.00 | 0.00 | 3.00 | 4.00 | 9.00 | 1.00 | 1.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 2.00 | 0.00 | 3,708.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-11-03 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 51.41 | 51.41 | 51.41 | 51.41 | 51.41 | 51.41 | 51.41 | 51.41 | 51.41 | 0.51 | 0.53 | 0.53 | 0.53 | 0.53 |
| Domestic institutions | 9.05 | 7.77 | 6.24 | 5.61 | 6.40 | 6.79 | 6.69 | 8.93 | 9.88 | 0.11 | 0.10 | 0.10 | 0.11 | 0.11 |
| Mutual funds | — | — | — | — | — | — | — | 6.60 | 5.37 | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 |
| Insurance companies | 1.99 | 0.56 | 1.11 | 1.03 | 1.24 | 0.64 | 1.13 | 2.21 | 4.43 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Foreign institutions | 6.57 | 7.07 | 7.12 | 6.68 | 5.29 | 5.00 | 5.23 | 5.59 | 5.52 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Government | — | — | — | — | — | — | — | 1.24 | 1.24 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 48.59 | 48.59 | 48.59 | 48.59 | 48.59 | 48.59 | 48.59 | 48.59 | 48.59 | 0.49 | 0.47 | 0.47 | 0.47 | 0.47 |
| Non-institutional | 31.74 | 32.51 | 33.99 | 35.07 | 35.66 | 35.57 | 35.43 | 32.84 | 31.95 | 0.31 | 0.29 | 0.30 | 0.29 | 0.28 |
| Shares outstanding | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 377462604 | 393462604 | 393462604 | 393462604 | 393462604 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Nanovace Technologies Limited | Wholly owned Subsidiary of PCBL Li | Investment | 1,408,300,000.00 | 2 |
| Rainbow Investments Limited | Parent under de facto control as d | Any other transaction | 952,500,000.00 | 5 |
| RPG Power Trading Company Limited | Company under common control | Any other transaction | 714,400,000.00 | 2 |
| PCBL TN Limited | Wholly Owned Subsidiary of PCBL Li | Any other transaction, Investment, Purchase of fixed | 390,900,000.00 | 7 |
| RPSG Resources Private Limited | Company under common control | Any other transaction | 329,300,000.00 | 4 |
| DIRECTOR COMMISSION | Directors | Any other transaction | 108,000,000.00 | 1 |
| Quest Capial Markets Limited | Company under common control | Any other transaction | 84,100,000.00 | 2 |
| STEL HOLDINGS LIMITED | Company under common control | Any other transaction | 84,000,000.00 | 1 |
| RPSG Ventures Limited | Company under common control | Any other transaction, Investment | 73,600,000.00 | 3 |
| KAUSHIK ROY | Managing Director | Any other transaction, Remuneration | 60,500,000.00 | 3 |
| Advaya Chemical Industries Limited | Subsidiary Company of PCBL Limited | Any other transaction, Loan | 50,000,000.00 | 3 |
| SUNIL BHANDARI | Employee holding Directorship in P | Any other transaction, Remuneration | 21,300,000.00 | 3 |
| Raj Kumar Gupta | Chief Financial Officer | Any other transaction, Remuneration | 16,600,000.00 | 3 |
| HARISH KR TOSHNIWAL | Employee holding Directorship in P | Any other transaction, Remuneration | 12,400,000.00 | 3 |
| KAUSHIK MUKHERJEE | Company Secretary and Key Manageme | Any other transaction, Remuneration | 12,300,000.00 | 3 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-08-05 | Q1FY27 | AQUAPHARM CHEMICAL, CHEMICAL LIMITED | Read the call |
| 2026-05-07 | Q4FY26 | CHEMICAL LIMITED | Read the call |
| 2026-02-09 | Q3FY26 | CHEMICAL LIMITED, RELATIONS | Read the call |
| 2025-10-24 | Q2FY26 | CHEMICAL LIMITED | Read the call |
| 2025-07-30 | Q1FY26 | CHEMICAL LIMITED, RELATIONS | Read the call |
| 2025-05-05 | Q4FY25 | CHEMICAL LIMITED, RELATIONS | Read the call |
| 2025-01-17 | Q3FY25 | CHEMICAL LIMITED | Read the call |
| 2024-11-06 | Q2FY25 | AND ESG REPORTING, LIMITED | Read the call |
Some earlier announcements under this heading are covering letters only — no transcript was attached.
What they said about it, quarter by quarter
| Topic | Q1FY26 | Q1FY27 | Q2FY25 | Q2FY26 | Q3FY25 | Q3FY26 | Q4FY25 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | How much capex we have, sir, in this business? | And any plans, any capex we have outlined there? | The carbon black business continues to be on a strong growth trajectory and is well poised to capture the growth in the domestic and exports market wi… | We also have commissioned a new plant of PBTC As you have seen before, it was a traded product for us for a long time, and now we have commissioned a … | At PCBL Chemical, we continue to work on portfolio expansion and capacity additions across business verticals, and we are increasing allocation of res… | We are working on new capacity addition on green chelates and from the existing capacities, which we have in the past, we have now, after a lot of eff… | I believe, sir, like we were also doing the Capex of around Rs. | And as I said, I'll get more details for you in the next call, where we would have already signed off the capex investment. |
| Capital allocation | — | — | Post the completion of the acquisition, we have been working on an integration process. | So, cash generation is likely to remain healthy and that probably gives the confidence to the board to maintain a strong dividend payout policy. | This growth, both organic and through strategic acquisition and partnerships, has brought us to a pivotal moment. | One last question is like this quarter, there was no dividend declaration. | 4,000 crore and as per accounting regulations in India, the difference between the value of physical assets and the acquisition value becomes intangib… | — |
| Costs | What are the steps that we are taking in terms of customer acquisition, then raw material sourcing and improving the conversion cost? | Q1 saw some challenges on the raw material availability, which affected production levels. | — | We would rather use them a lot for our buying raw materials, okay, for the oil & gas market. | And you're aware that our principal raw material is a derivative of crude, which has an impact on our realization. | That's more of raw material for some of their end products. | It is more reflective of the movement in raw material prices, which is linked to crude. | — |
| Debt and cash | But the other thing is, as an organization, to take care of the situation in terms of performance, we are taking a lot of initiatives internally, whic… | — | Just want to know, so that can Rs.2,000 crore annual cash flow number be maintained for the next two, three years? | Our working capital cycle improved by 12 days in H1 FY'26, releasing around Rs. | And in order to show better capital efficiency, generally there is a tendency to reduce working capital levels and therefore, de-stocking. | But the recent presentation mentions that there is a release in working capital and which was used for reduction in debt. | 5,000-6,000 crores and the cash flow which we would be generating largely would be used for that expansion going ahead. | Considering there is a sharp increase in the feedstock prices, that will put significant pressure on working capital and hence on the net debt positio… |
| Demand | But at the same time, you need to understand there are markets where supply is less than demand and U.S., Europe are examples for that. | In water treatment, demand remains strong across regions, especially with newer use cases like data centers coming up, and we are scaling our phosphon… | Sir, my first question is that in the carbon black business, according to a previous presentation given by the Company, so just wanted to understand t… | Domestic tyre demand is projected to grow at 6-8% in FY'26, led by stronger replacement demand in the second half. | Specialty chemicals, generally, I mean, this whole industry is facing a lot of headwinds in form of tepid demand and also stiff competition from China… | Secondly, if you see on multiple product sides, practically, primary reason of Aquapharm not doing well in the last quarter was a decent degrowth in t… | So, demand seems to be muted for carbon black in domestic. | And what are the triggers wherein it can improve apart from what we say that tyre demand will grow? |
| Guidance | As I said, I don't want to give you any guidance for this. | And I agree with Rajji's comment that we expect some hiccups in the next quarter, but on a full year basis, we are looking at sustainably managing our… | We expect significant growth in international sales volume to European markets. | However, as US continues to be imported dependent for carbon black, we expect both volume and margin to recover once the situation stabilizes. | We expect strong growth both in sales volume and in operating margins in the ensuing financial year. | So, I think overall, while Aquapharm has not grown as we anticipated, but we believe in the coming few quarters, you will see a gradual upward movemen… | Sir, my first question is on to the outlook for the Carbon Black. | A combination of this, does it improve the outlook for Aquapharm in FY27? |
| Margin | Sir, for the whole year, can we see this EBITDA per kg to be maintained at INR17-18 per kg? | So EBITDA per kg looks at around INR20,000 per ton or INR20 per kg. | Consolidated EBITDA grew by about 53% year-on-year to Rs. | Our specialty and solution segment under Aquapharm witnessed a gross margin improvement of 10% on the back of a better product mix. | Consolidated EBITDA in the same period grew by around 15% to INR328 crores, while PBT stood at INR124 crores and PAT at INR93 crores. | But operating leverage has played negatively. | And sir secondly, in FY '25 the EBITDA was Rs. | There's not much improvement at EBITDA per ton level. |
| People | We'll maintain this kind of capacity utilization a little higher. | The capacity utilization in Aquapharm still remains low, and therefore, the number for the quarter, there is an upside to it. | The Company is implementing various cost optimization and operational efficiency measures which would result in better capacity utilization, leading t… | In Q2 FY'26, PCBL Chemical reported healthy growth in carbon black sales volume on both YoY as well as QoQ basis and improved capacity utilization acr… | This translates into a capacity utilization of over 90% during the quarter. | And at full utilization level, it should generate somewhere around close to about Rs. | Now, we want to keep our capacity utilization high and therefore we still booked some volumes which were not at our usual margins. | From a profitability perspective what has happened is significantly lower capacity utilization in the last couple of quarters. |
| Pricing | Sir, my first question is in the Rubber Carbon Black segment, next pricing cycle negotiations are scheduled to begin in the month of August with the r… | So we'll hold on to pricing discipline as long as we can see that our ability to push volumes in market is high. | — | However, the margins are impacted by continued pricing pressure in a relatively softer market environment. | Sir, second question was with regards to usually in this quarter or in this period, there are negotiations with customers regarding pricing on the Car… | So, the movement in crude becomes built into the pricing and passed on to the customers on a very macro level. | And consequently, with our focus on capacity utilization, we also have to play a bit on pricing, which is reflected in the drop in margins in the curr… | Of course, after the West Asia crisis, we were forced to increase even more prices, but structurally we have been able to improve some pricing in that… |
| Revenue growth | In 3-4 years' time, this business as it becomes bigger in terms of top line, we'll start getting better and better returns on capital. | Aquapharm reported sales volumes of 22,985 metric tons, revenue of INR394 crores and EBITDA of INR47 crores in Q1 FY27. During this quarter, home care… | Export sales volume registered a strong year-on-year growth of 22% in Q2 FY '25. | Our Home Care business delivered promising growth of 18% QOQ (Q2 FY'26 versus Q1 FY'26) in quantity sold driven mostly by expanded reach and stronger … | Sir, we had already guided for FY ‘25 volume growth of 15- 20%? | Both in the domestic market, it will be in line with the growth of the market. | — | Even if crude remains at $90 level, I think considering the volume growth, the revenue growth, we will require another INR100 crores worth of incremen… |